Axantia Selects TrackWise Digital to Enable Digital Quality Management Across Middle East Pharmaceutical Operations December 15, 2020 Leading pharmaceutical group implements digital QMS to automate and seamlessly connect quality, document and training management processes HAMILTON, NJ – DECEMBER 15, 2020 – Today, Sparta Systems announced that Axantia Cayman Holdings, a leading pharmaceutical group headquartered in Amman, with manufacturing operations in Jordan and Saudi Arabia, has selected TrackWise Digital® as its cloud-based, end-to-end quality management platform. Axantia develops, manufactures, markets and distributes high-quality branded generic pharmaceuticals and under-licensed products in 20 countries across the Middle East, Africa and the CIS.Axantia will implement the TrackWise Digital suite for core Quality processes (Quality Events, CAPA, Change Control), Complaints Management, Supplier Quality Management, Document Management, and Training Management to integrate quality processes and data across its manufacturing operations and suppliers.“At Axantia, one of our core values is developing and manufacturing superior quality pharmaceutical products. We needed a solution that would support the high-quality standards that we’ve set for serving our customers. Having successfully administered over seventy internal and external audits in different countries, I saw firsthand that the TrackWise Digital brand is the de facto standard for QMS excellence.” said Abdullah Othman, Axantia Executive Director Quality. “With TrackWise Digital, we can move to the cloud while simultaneously automating and connecting all of our quality-related processes. Being able to digitize our QMS and enable access from anywhere at any-time via mobile devices has been critical in ensuring business continuity in the current pandemic climate.”TrackWise Digital will support Axantia’s digital transformation initiative through integration with their ERP, LIMS and Asset Management systems. This will streamline business critical processes and enable greater operational agility as they expand their business.“For high growth generic pharmaceutical manufacturers like Axantia, who are committed to quality products and patient safety, selecting the right QMS is a mission critical decision.” Said Stephen McCarthy, Sparta Vice President of Digital Innovation. “With TrackWise Digital, Axantia has a future-proofed QMS platform that will deliver new levels of operational efficiency, supporting their quality and compliance needs today and tomorrow, as they expand their business globally.” Download a PDF of this Press Release About Axantia Axantia is a regional leader in generic medicines committed to improving health outcomes, cost of care, and the general well-being of patients, an experienced yet agile player in the MENA pharma market. Press Release Axantia is one of the top 10 key players in the generic pharmaceutical industry in the MENA region. Since our establishment in Jordan in 1994, we have cultivated a thriving culture of innovation, amply demonstrated by the depth and breadth of our product portfolio of over 200 products spanning across key therapeutic classes, including Anti-infectives, Cardiovascular and diabetes, Nervous System, Respiratory System and Lifestyle conditions. Operating in 18 countries across MENA and investing in expanding our footprint constantly. Visit www.axantia.com for more info. About Sparta Systems Sparta’s industry-leading quality management systems bring together an organization’s quality processes in a single place, increasing efficiency and performance while helping to achieve compliance and reduce risk. Sparta is the provider of TrackWise® enterprise QMS software and TrackWise Digital®, a next-generation, cloud and digital QMS SaaS service. With nearly a million users in more than 30 countries, companies in life sciences and other industries rely on Sparta’s expertise and solutions to optimize quality and help them deliver safe and effective products to patients and customers. Leading companies who rely on TrackWise Digital include Alkermes, Arbor Pharmaceutical, bioMerieux, Endo Pharmaceuticals, McKesson, Pfizer, Roche Diagnostics, SGS and Thermo Fisher Scientific.